Myeloma Paper of the Day, June 21st, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Myeloma cells can rapidly adapt to induction treatment via transcriptional adaptation, metabolic adaptation, and specialized immune evasion, and targeting therapy-induced resistance mechanisms may help avert refractory disease.”
Source: Robert Orlowski/X
Authors: Jian Cui, Xiaoyun Li, Shuhui Deng, Chenxing Du, Huishou Fan, Wenqiang Yan, Jingyu Xu, Xiaoqing Li, Tengteng Yu, Shuaishuai Zhang, Rui Lv, Weiwei Sui, Mu Hao, Xin Du, Yan Xu, Shuhua Yi, Dehui Zou, Tao Cheng, Lugui Qiu, Xin Gao and Gang An.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
